Approval · Notice of Compliance 9843 · 2008
REBIF: Notice of Compliance 9843
Issued October 20, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9843
- Date
- October 20, 2008
- Company
- Emd Serono Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New presentations
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REBIF | 02318253 | Marketed |
| REBIF | 02318261 | Marketed |
| REBIF (INITIATION PACK) | 02318288 | Cancelled Pre Market |
Medicinal ingredients
- INTERFERON BETA-1A 66 MCG per 1.5ML
- INTERFERON BETA-1A 132 MCG per 1.5ML